Abu El-Asrar AM, Dralands L, Veckeneer M, Geboes K, Missotten L, Van Aelst I, Opdenakker G. Gelatinase B in proliferative vitreoretinal disorders. Am J Ophthalmol. 1998; 125(6): 844-851.
Al-Gayer, MM, Abdelhadi, MA, Matragoon, S, Pillai BA, El-Remiss AB. Neurovascular protective effect of Epps in N-methyl-D-aspartate model: similarities to diabetes. Am. J. Pathol. 2010, 177(3): 1187–1197.
Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol. 2011, 164: 170–180.
Aoki Y, Nakahara T, Asano D, Ushikubo H, Mori A, Sakamoto K, Ishii K. Preventive effects of rapamycin on inflammation and capillary degeneration in a rat model of NMDA-induced retinal injury. Biol Pharm Bull. 2015; 38(2): 321-324.
Arita R, Nakao S, Kita T, Kawahara S, Asato R, Yoshida S, Enaida H, Hafezi-Moghadam A, Ishibashi T. A key role for ROCK in TNF-α-mediated diabetic microvascular damage. Invest Ophthalmol Vis Sci. 2013, 54(3): 2373-2383.
Asami, Y, Nakahara, T, Asano, D, Kurauchi, Y, Mori, A, Sakamoto, K, Ishii, K. Age-dependent changes in the severity of capillary degeneration in rat retina following N-methyl-D-aspartate- induced neurotoxicity. Curr. Eye Res. 2015, 40(5): 549–553.
Azuma N, Shiraga F. Guidance of medical care for familial exudative vitreoretinopathy：Research on rare and intractable diseases, health and labour sciences research grants. J Jpn Ophthalmol Soc. 2017, 121: 487-497.
Bading H, Segal MM, Sucher NJ, Dudek H, Lipton SA, Greenberg ME. N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons. Neuroscience. 1995, 64: 653–664.
Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol. 2008, 172: 1411–1418.
Brandstätter JH, Koulen P, Wässle H. Selective synaptic distribution of kainate receptor subunits in the two plexiform layers of the rat retina. J Neurosci. 1997, 17(23): 9298-9307.
Chang ML, Wu CH, Jiang-Shieh YF, Shieh JY, Wen CY. Reactive changes of retinal astrocytes and Müller glial cells in kainate-induced neuroexcitotoxicity. J. Anat. 2007, 210: 54–65.
Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye. 2008, 22(6):855-859.
Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J. Biol. Chem. 2002, 277: 47461–47468.
De Groef L, Van Hove I, Dekeyster E, Stalmans I, Moons L. MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair? Invest. Ophthalmol. Vis. Sci. 2014, 55: 1953–1964.
Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 2009, 335(1): 17-25.
Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S. Determination of vitreous interleukin- 1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye. 2006, 20: 1366–1369.
Descamps FJ, Martens E, Kangave D, Struyf S, Geboes K, Van Damme J, Opdenakker G, Abu El-Asrar AM. The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. Exp Eye Res. 2006, 83(2): 401-407.
Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Investig. Ophthalmol. Vis. Sci. 2002, 43: 3500–3510.
Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional control of the TNF gene. Curr Dir Autoimmun. 2010, 11:27-60.
Fanjul-Fernández M, Folgueras AR, Cabrera S, López-Otín C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010, 1803(1): 3-19.
Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Investig. Ophthalmol. Vis. Sci. 2003, 44, 839e847.
Fletcher EL, Hack I, Brandstätter JH, Wässle H. Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol. 2000, 420(1): 98-112.
Ganesh BS, Chintala SK. Inhibition of reactive gliosis attenuates excitotoxicity-mediated death of retinal ganglion cells. PLoS One 2011, 6(3): e18305.
Ganguly K, Rejmak E, Mikosz M, Nikolaev E, Knapska E, Kaczmarek L. Matrix metalloproteinase (MMP) 9 transcription in mouse brain induced by fear learning. J. Biol. Chem. 2013. 288: 20978–20991.
Goldfeld AE, Flemington EK, Boussiotis VA, Theodos CM, Titus RG, Strominger JL, Speck SH. Transcription of the tumor necrosis factor α gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci. 1992, 89:12198– 12201.
Goldfeld AE, McCaffrey PG, Strominger JL, Rao A. Identification of a novel cyclosporin- sensitive element in the human tumor necrosis factor α gene promoter. J Exp Med. 1993, 178:1365–1379.
Goldfeld AE, Strominger JL, Doyle C. Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med. 1991, 174: 73–81.
Gründer T, Kohler K, Guenther E. Distribution and Developmental Regulation of AMPA Receptor Subunit Proteins in Rat Retina. Invest Ophthalmol Vis Sci. 2000, 41(11): 3600-3606.
Gründer T, Kohler K, Kaletta A, Guenther E. The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the rat. J Neurobiol. 2000, 44(3): 333-342.
Guinea-Viniegra J, Zenz R, Scheuch H, Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M, Wagner EF. TNF-alpha shedding and epidermal inflammation are controlled by Jun proteins. Genes Dev. 2009, 23(22): 2663-2674.
Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest. Ophthalmol. Vis. Sci. 2005, 46: 175–182.
Hack I1, Koulen P, Peichl L, Brandstätter JH. Development of glutamatergic synapses in the rat retina: the postnatal expression of ionotropic glutamate receptor subunits. Vis Neurosci. 2002, 19(1):1-13.
Han YP, Nien YD, Garner WL. Tumor necrosis factor-alpha-induced proteolytic activation of pro- matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem. 2002, 277(30): 27319-27327.
Hartveit E, Brandstätter JH, Sassoè-Pognetto M, Laurie DJ, Seeburg PH, Wässle H. Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina. J. Comp. Neurol. 1994, 348, 570–582.
Hayashi I, Aoki Y, Asano D, Ushikubo H, Mori A, Sakamoto K, Nakahara T, Ishii K. Protective Effects of Everolimus against N-Methyl-D-aspartic Acid-Induced Retinal Damage in Rats. Biol Pharm Bull. 2015, 38(11): 1765-1771.
Hollmann, M, Heinemann, S. Cloned glutamate receptors. Ann. Rev. Neurosci. 1994, 17: 31–108.
Honjo, M, Tanihara, H, Kido, N, Inatani, M, Okazaki, K, Honda, Y. Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest. Ophthalmol. Vis. Sci. 2000, 41(2): 552–560.
Iwakura Y, Wang R, Inamura N, Araki K, Higashiyama S, Takei N, Nawa H. Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons. PLoS One. 2017, 12(3): e0174780.
Jayashree K, Yasir M, Senthilkumar GP, Ramesh Babu K, Mehalingam V, Mohanraj PS. Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy. Diabetes Metab. Syndr. 2018, 12(6): 869-873.
Jiang B, Liou GI, Behzadian MA, Caldwell, R.B. Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression. J. Cell Sci. 1994, 107: 2499–2508.
Jin M, Kashiwagi K, Izuka Y, Tanaka Y, Imai M, Tsukahara S. Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina. 2001, 21: 28–33.
Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, Declerck YA. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res. 2005, 65(8):3200-3208.
Kiagiadaki F, Thermos K. Effect of intravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina. Invest. Ophthalmol. Vis. Sci. 2008, 49(7), 3080– 3089.
Kluger MA, Zahner G, Paust HJ, Schaper M, Magnus T, Panzer U, Stahl RA. Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int. 2013, 83(5): 865-877.
Kolaczkowska E, Chadzinska M, Scislowska-Czarnecka A, Plytycz B, Opdenakker G, Arnold B. Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Immunobiology. 2006, 211(3): 137-148.
Kolaczkowska E, Lelito M, Kozakiewicz E, van Rooijen N, Plytycz B, Arnold B. Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells. Immunol Lett. 2007, 113(2): 99-106.
Kosano H, Okano T, Katsura Y, Noritake M, Kado S, Matsuoka T, Nishigori H. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. Life Sci. 1999,
(25): 2307-2315.
Kowluru RA, Mishra M. Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy. Prog. Mol. Biol. Transl. Sci. 2017, 148: 67–85.
Lam TT, Abler AS, Kwong JM, Tso MO. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest. Ophthalmol. Vis. Sci. 1999, 40(10), 2391–2397.
Lee SJ, Park SS, Cho YH, Park K, Kim EJ, Jung KH et al. Activation of matrix metalloproteinase- 9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncol Rep. 2008, 19(4):1007-1013.
Limb GA, Daniels JT, Pleass R, Charteris DG, Luthert PJ, Khaw PT. Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha. Am J Pathol. 2002, 160(5): 1847-1855.
Lomniczi A, Cornea A, Costa ME, Ojeda SR. Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain. J Neurosci. 2006, 26(1): 51-62.
Lucas-Ruiz F, Galindo-Romero C, Salinas-Navarro M, González-Riquelme MJ, Vidal-Sanz M,Agudo Barriuso M. Systemic and Intravitreal Antagonism of the TNFR1 signaling pathway delays axotomy-induced retinal ganglion cell loss. Front Neurosci. 2019, 13: 1096.
Mali RS, Cheng M, Chintala SK. Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9. Invest. Ophthalmol. Vis. Sci. 2005, 46: 2125–2132.
Manabe S, Gu Z, Lipton SA. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 2005, 46,:4747–4753.
Mathalone N, Lahat N, Rahat MA, Bahar-Shany K, Oron Y, Geyer O. The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 2007. 245: 725–732.
Mohammad G, Siddiquei MM. Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy. J. Ocul. Biol. Dis. Infor. 2012, 5: 1–8.
Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004, 36(9): 969-977.
Mori H, Mishina M. Neurotransmitter receptors. Structure and function of the NMDA receptor channel. Neuropharmacology. 1995, 34(10): 1219–1237.
Morizane C, Adachi K, Furutani I, Fujita Y, Akaike A, Kashii S, Honda Y. N(omega)-nitro-L- arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur. J. Pharmacol. 1997, 328(1): 45–49.
Mukherjee TK, Mukhopadhyay S, Hoidal JR. The role of reactive oxygen species in TNFalpha- dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta. 2005 Jun 30;1744(2):213-23
Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. Lab Invest. 1996, 74(1): 68-77.
Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs.Cardiovasc. Res. 2006, 69: 562–573.
Nakahara T, Hoshino M, Hoshino S, Mori, A, Sakamoto K, Ishii K. Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats. Exp Eye Res. 2015, 135(6): 134–145.
Nakahara T, Mori A, Kurauchi Y, Sakamoto K, Ishii K. Neurovascular interactions in the retina: physiological and pathological roles. J. Pharmacol. Sci. 2013, 123(2), 79–84.
Nakazawa T, Takahashi H, Nishijima K, Shimura M, Fuse N, Tamai M, Hafezi-Moghadam A, Nishida K. Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J Neurochem. 2007 , 100(4): 1018-1031.
Newman EA. Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters. Philos. Trans, R Soc, Lond, B Biol, Sci. 2015, 370.
Nita M, Strzałka-Mrozik B, Grzybowski A, Mazurek U, Romaniuk W. Age-related macular degeneration and changes in the extracellular matrix. Med. Sci. Monit. 2014, 20: 1003–1106.
Nusbaum HC, Schwab EC. The role of attention and active processing in speech perception. In Nusbaum HC, Schwab EC (Eds.) Pattern recognition by humans and Machines. 1986, Academic Press, pp.113-157.
Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 1992, 267: 21712–21719.
Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol. 2000, 156: 697–707.
Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996. 114: 1219–1228.
Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA. 1995, 92: 905–909.
Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honoré JC, Kermorvant- Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beauséjour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S.The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008, 14(10): 1067-1076.
Shen Y, Liu XL, Yang XL. N-methyl-D-aspartate receptors in the retina. Mol Neurobiol. 2006, 34(3): 163-179.
Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002, 21(1): 1-14.
Stenzel D, Lundkvist A, Sauvaget D, Busse M, Graupera M, van der Flier A, Wijelath ES, Murray J, Sobel M, Costell M. Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Development. 2011, 138: 4451–4463.
Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995, 15: 4738-4747.
Stone J, Chan-Ling T, Pe’er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Investig. Ophthalmol. Vis. Sci. 1996, 37: 290–299.
Tsai CL, Chen WC, Hsieh HL, Chi PL, Hsiao LD, Yang CM. TNF-α induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2- mediated MAPKs and NF-κB activation in osteoblast-like MC3T3-E1 cells. J Biomed Sci. 2014, 21(1): 12.
Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Honda Y. Tacrolimus (FK506) attenuates leukocyte accumulation after transient retinal ischemia. Stroke. 1998, 29(7): 1431-1437.
Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Tojo SJ, Miyasaka M, Honda Y. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest Ophthalmol Vis Sci. 1999, 40(6): 1183-1190.
Ueda K, Nakahara T, Hoshino M, Mori A, Sakamoto K, Ishii K. Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration. Neurosci. Lett. 2010, 485(1): 55–59.
Vempati P, Karagiannis ED, Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem. 2007, 282(52):37585-37596.
Vorwerk CK, Hyman BT, Miller JW, Husain D, Zurakowski D, Huang PL, Fishman MC, Dreyer EB. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest. Ophthalmol. Vis. Sci. 1997, 38(10): 2038–2044.
Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 1996, 16: 5425–5436.
Zalewska R, Reszeć J, Kisielewski W, Mariak Z. Metalloproteinase 9 and TIMP-1 expression in retina and optic nerve in absolute angle closure glaucoma. Adv. Med. Sci. 2016, 61: 6–10.
Zhang X, Cheng M, Chintala SK. Kainic acid-mediated upregulation of matrix metalloproteinase- 9 promotes retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2004, 45: 2374–2383.
Zhang X, Chintala SK. Influence of interleukin-1 beta induction and mitogen-activated protein kinase phosphorylation on optic nerve ligation-induced matrix metalloproteinase-9 activation in the retina. Exp. Eye Res. 2004, 78: 849–860.
Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia- reperfusion injury in rats. Exp. Eye Res. 2002, 74: 577–584.
Zheng L, Gong B, Hatala DA, Kern TS. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest. Ophthalmol. Vis. Sci. 2007, 48, 361–367.
Zhou P, Lu S, Luo Y, Wang S, Yang K, Zhai Y, Sun G, Sun X. Attenuation of TNF-α-Induced Inflammatory Injury in endothelial cells by ginsenoside rb1 via inhibiting NF-κB, JNK and p38 signaling pathways. Front Pharmacol. 2017, 8: 464.
Zimmerman M. Neurophysiology of Sensory Systems. In “Fundamentals of sensory Physiology”, Schmidt RF (Ed), Springer-verlag, 1978: 1-18.
Zunke F, Rose-John S. The shedding protease ADAM17: Physiology and pathophysiology. Biochim Biophys Acta Mol Cell Res. 2017, 1864: 2059-2070.
論文の公開元へ
